pridopidine: Clinical Trials

6 trials of pridopidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 active not recruiting. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Recruiting 2, Active not recruiting 1
Phase 22Active not recruiting 1, Completed 1

Follow pridopidine: new trials by email Literature Review of pridopidine trials Research Report on pridopidine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pridopidine Phase 3 Study in Huntington's Disease
Pridopidine, Placebo - Huntington Disease
Phase 3RecruitingPrilenia4002026-07-012026-11-04
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Pridopidine, Placebo - Amyotrophic Lateral Sclerosis
Phase 3RecruitingPrilenia5002026-02-012026-11-17
HEALEY ALS Platform Trial - Regimen D Pridopidine
Pridopidine, Matching Placebo - Amyotrophic Lateral Sclerosis
Phase 2 / Phase 3CompletedMerit E. Cudkowicz, MD1632020-12-182023-08-23
PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD
Pridopidine, Placebo - Huntington Disease
Phase 3CompletedPrilenia4992020-10-162025-03-12
HEALEY ALS Platform Trial - Master Protocol
Zilucoplan, Verdiperstat, CNM-Au8 - Amyotrophic Lateral Sclerosis
Phase 2 / Phase 3Active not recruitingMerit E. Cudkowicz, MD15002020-06-142026-07-21
A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease
ACR16, Placebo - Huntington's Disease
Phase 3CompletedTeva Branded Pharmaceutical Products R&D, Inc.4372008-04-242023-08-29

Conditions studied

Amyotrophic Lateral Sclerosis (3)  ·  Huntington Disease (3)

Sponsors

Prilenia (3)  ·  Merit E. Cudkowicz, MD (2)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (1)

Countries

United States (5)  ·  France (4)  ·  Germany (4)  ·  Italy (4)  ·  Spain (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Canada (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Austria (2)  ·  Czechia (2)  ·  Portugal (2)  ·  Ireland (1)  ·  Israel (1)

Top investigators

Merit Cudkowicz, MD (2)  ·  Yael Cohen (1)

Results publications

PMID 40067755, PMID 22071279, PMID 36811812, PMID 39960672, PMID 40067754, PMID 40067821, PMID 40913168, PMID 41406304